EXOZ
Price
$4.56
Change
+$0.01 (+0.22%)
Updated
Oct 14 closing price
Capitalization
55.69M
Intraday BUY SELL Signals
LIMN
Price
$3.25
Change
-$0.16 (-4.69%)
Updated
Oct 14 closing price
Capitalization
5.74M
Intraday BUY SELL Signals
Interact to see
Advertisement

EXOZ vs LIMN

EXOZ vs LIMN Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
EXOZ vs. LIMN commentary
Oct 15, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is EXOZ is a Hold and LIMN is a Hold.

Interact to see
Advertisement
SUMMARIES
A.I.Advisor
a Summary for EXOZ with price predictions
Oct 14, 2026

Momentum Indicator for EXOZ turns negative, indicating new downward trend

EXOZ saw its Momentum Indicator move below the 0 level on September 25, 2026. This is an indication that the stock could be shifting in to a new downward move. Traders may want to consider selling the stock or exploring put options. Tickeron's A.I.dvisor looked at 29 similar instances where the indicator turned negative. In 28 of the 29 cases, the stock moved further down in the following days. The odds of a decline are at 90%.

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

EXOZ moved below its 50-day moving average on October 02, 2026 date and that indicates a change from an upward trend to a downward trend.

The 10-day moving average for EXOZ crossed bearishly below the 50-day moving average on October 05, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 4 of 5 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 80%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where EXOZ declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 85%.

The Aroon Indicator for EXOZ entered a downward trend on October 13, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Bullish Trend Analysis

The RSI Indicator shows that the ticker has stayed in the oversold zone for 3 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an Uptrend is expected.

The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 12 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.

Following a +3.88% 3-day Advance, the price is estimated to grow further. Considering data from situations where EXOZ advanced for three days, in 76 of 83 cases, the price rose further within the following month. The odds of a continued upward trend are 90%.

EXOZ may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of 58 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (15.267) is normal, around the industry mean (26.782). P/E Ratio (0.000) is within average values for comparable stocks, (43.395). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (9.059). Dividend Yield (0.000) settles around the average of (0.000) among similar stocks. P/S Ratio (0.000) is also within normal values, averaging (437.542).

The Tickeron Price Growth Rating for this company is 90 (best 1 - 100 worst), indicating slightly worse than average price growth. EXOZ’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is 100 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is 100 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. EXOZ’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.

A.I.Advisor
a Summary for LIMN with price predictions
Oct 14, 2026

LIMN in +5.28% Uptrend, growing for three consecutive days on October 05, 2026

Moving higher for three straight days is viewed as a bullish sign. Keep an eye on this stock for future growth. Considering data from situations where LIMN advanced for three days, in 49 of 87 cases, the price rose further within the following month. The odds of a continued upward trend are 56%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 6 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.

The Moving Average Convergence Divergence (MACD) for LIMN just turned positive on September 22, 2026. Looking at past instances where LIMN's MACD turned positive, the stock continued to rise in 25 of 50 cases over the following month. The odds of a continued upward trend are 50%.

LIMN may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on October 06, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on LIMN as a result. In 32 of 108 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 30%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where LIMN declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 72%.

The Aroon Indicator for LIMN entered a downward trend on September 23, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of 63 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (19.084) is normal, around the industry mean (26.782). P/E Ratio (0.000) is within average values for comparable stocks, (43.395). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (9.059). Dividend Yield (0.000) settles around the average of (0.000) among similar stocks. P/S Ratio (0.000) is also within normal values, averaging (437.542).

The Tickeron Price Growth Rating for this company is 89 (best 1 - 100 worst), indicating slightly worse than average price growth. LIMN’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is 100 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is 100 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. LIMN’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.

TECHNICAL ANALYSIS
Technical Analysis
EXOZLIMN
RSI
ODDS (%)
Bullish Trend 1 day ago
90%
N/A
Stochastic
ODDS (%)
Bullish Trend 1 day ago
90%
Bullish Trend 1 day ago
50%
Momentum
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
30%
MACD
ODDS (%)
N/A
Bullish Trend 1 day ago
50%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
83%
Bearish Trend 1 day ago
46%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
74%
Bearish Trend 1 day ago
53%
Advances
ODDS (%)
Bullish Trend 21 days ago
90%
Bullish Trend 10 days ago
56%
Declines
ODDS (%)
Bearish Trend 2 days ago
85%
Bearish Trend 1 day ago
72%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
89%
Bullish Trend 1 day ago
50%
Aroon
ODDS (%)
Bearish Trend 1 day ago
69%
Bearish Trend 1 day ago
50%
COMPARISON
Comparison
Oct 15, 2026
Stock price -- (EXOZ: $4.56 vs. LIMN: $3.25)
Brand notoriety: EXOZ and LIMN are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: EXOZ: 124% vs. LIMN: 8%
Market capitalization -- EXOZ: $55.69M vs. LIMN: $5.74M
EXOZ [@Biotechnology] is valued at $55.69M. LIMN’s [@Biotechnology] market capitalization is $5.74M. The market cap for tickers in the [@Biotechnology] industry ranges from $58 to $133.74B. The average market capitalization across the [@Biotechnology] industry is $2.21B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

EXOZ’s FA Score shows that 0 FA rating(s) are green while LIMN’s FA Score has 0 green FA rating(s).

  • EXOZ’s FA Score: 0 green, 5 red.
  • LIMN’s FA Score: 0 green, 5 red.
According to our system of comparison, both EXOZ and LIMN are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

EXOZ’s TA Score shows that 4 TA indicator(s) are bullish while LIMN’s TA Score has 4 bullish TA indicator(s).

  • EXOZ’s TA Score: 4 bullish, 5 bearish.
  • LIMN’s TA Score: 4 bullish, 3 bearish.
According to our system of comparison, LIMN is a better buy in the short-term than EXOZ.

Price Growth

EXOZ (@Biotechnology) experienced а -17.39% price change this week, while LIMN (@Biotechnology) price change was -16.24% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -8.52%. For the same industry, the average monthly price growth was -19.04%, and the average quarterly price growth was -19.99%.

Industries' Descriptions

@Biotechnology (-8.52% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

View a ticker or compare two or three
EXOZ
Daily Signal:
Gain/Loss:
LIMN
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
FXH131.601.71
+1.32%
First Trust Health Care AlphaDEX Fund (FXH)
PSL112.811.20
+1.08%
Invesco Dorsey Wright Consumer Staples Momentum ETF (PSL)
CVSB50.51-0.01
-0.02%
Calvert Ultra-Short Investment Grade ETF (CVSB)
MFLX15.97-0.01
-0.09%
First Trust Flexible Municipal High Income ETF (MFLX)
MSML70.46-1.06
-1.48%
iShares MSCI USA Small-Cap ETF (MSML)

EXOZ and

Correlation & Price change

A.I.dvisor tells us that EXOZ and CTNM have been poorly correlated (+24% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that EXOZ and CTNM's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To EXOZ
1D Price
Change %
EXOZ100%
+0.22%
CTNM - EXOZ
24%
Poorly correlated
-3.33%
EDVA - EXOZ
21%
Poorly correlated
-0.92%
ORIC - EXOZ
21%
Poorly correlated
+2.48%
MENS - EXOZ
11%
Poorly correlated
+0.49%
LIMN - EXOZ
9%
Poorly correlated
-4.69%
More

LIMN and

Correlation & Price change

A.I.dvisor indicates that over the last year, LIMN has been loosely correlated with FTH. These tickers have moved in lockstep 35% of the time. This A.I.-generated data suggests there is some statistical probability that if LIMN jumps, then FTH could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To LIMN
1D Price
Change %
LIMN100%
-4.69%
FTH - LIMN
35%
Loosely correlated
-7.02%
UPB - LIMN
35%
Loosely correlated
-3.66%
IMMP - LIMN
34%
Loosely correlated
-5.32%
RNA - LIMN
32%
Poorly correlated
-0.90%
ALDX - LIMN
31%
Poorly correlated
-12.16%
More